Molecular and cellular pathobiology identification of susceptibility loci in a mouse model of KRASG12D-driven pancreatic cancer

Cancer Research

Volumn 70, Issue 21, 2010, Pages 8398-8406

  Jorgenson, Tonia C ^a   Williams, Bret R ^a,c   Wendland, Allyson ^b   Bilger, Andrea ^a   Sandgren, Eric P ^b   Drinkwater, Norman R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; KRAS PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 12; CHROMOSOME 2; CHROMOSOME 4; CONTROLLED STUDY; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; QUANTITATIVE TRAIT LOCUS MAPPING; TRANSGENIC MOUSE; Y CHROMOSOME; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CHROMOSOME; CHROMOSOME MAP; DBA MOUSE; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; MALE; METABOLISM; MUTATION; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL DIFFERENTIATION; CHROMOSOME MAPPING; CHROMOSOMES; DISEASE PROGRESSION; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, NUDE; MUTATION; PANCREATIC NEOPLASMS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; QUANTITATIVE TRAIT LOCI; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSGENES;

EID: 78449270064     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3980     Document Type: Article

References (39)

1. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2009, p. 10
2. Katz MHG, Hwang R, Fleming J, et al. Tumor node metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 2008;58:111-25.
3. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006;20:1218-49.
4. Guerra C, Schuhmacher AJ, Canamero M, et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007;11:291-302.
5. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-Kras genes. Cell 1988;53: 549-54.
6. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-86.
7. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-87.
8. Ottenhof NA, Milne NA, Morsink FN, et al. Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis of mice and men. Arch Pathol Lab Med 2009;133:375-81.
9. Friedlander SYG, Chu GC, Snyder EL, et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 2009;16:379-89.
10. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:427-50.
11. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 2006;66: 95-106.
12. Bardeesy N, Aguirre AJ, Chu GC, et al. Both p16Ink4a and the p19Arf p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A 2006;103:5947-52.
13. Wennerberg K, Rossman KL, Channing JD. The Ras superfamily at a glance. J Cell Sci 2005;118:843-6.
14. Li G, Zhang XC. GTP hydrolysis mechanism of Ras-like GTPases. J Mol Biol 2004;340:921-32.
15. Zuber J, Tchernitsa OI, Hinzmann B, et al. A genome-wide survey of Ras transformation targets. Nat Genet 2000;24:144-52.
16. Grippo PJ, Nowlin PS, Demeure MJ, et al. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 2003;63:2016-9.
17. Witmer PD, Doheny KF, Adams MK, et al. The development of a highly informative mouse Simple Sequence Length Polymorphism (SSLP) marker set and construction of a mouse family tree using parsimony analysis. Genome Res 2003;13:485-91.
18. Rasband WS. ImageJ. Bethesda (MD): U.S. National Institutes of Health; 1997-2010. Available from: http://rsb.info.nih.gov/ij/.
19. Bilger A, Bennett LM, Carabeo RA, et al. A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines. Genetics 2004;167:859-66.
20. Dietrich WF, Miller J, Steen MA, et al. A comprehensive genetic map of the mouse genome. Nature 1996;380:149-52.
21. Kruglyak L, Lander ES. A nonparametric approach for mapping quantitative trait loci. Genetics 1995;139:1421-8.
22. Lehman EL. Nonparametrics: statistical methods based on ranks. Upper Saddle River (NJ): Prentice-Hall; 1998.
23. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994;138:963-71.
24. Fisher RA. Statistical methods for research workers. New York: Hafner; 1973.
25. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003;19:889-90.
26. GenBank. Bethesda (MD): National Center for Biotechnology Information, National Library of Medicine; 2010. Available from: http://www.ncbi.nlm.nih.gov.
27. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using realtime RT-PCR. Nat Protocols 2006;1:1559-81.
28. Vandesompele J, DePreter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:research0034.1-11.
29. Mouse HapMap Imputed Genotype Resource. Los Angeles (CA); 2009. Available from: http://mouse.cs.ucla.edu/mousehapmap/.
30. AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 2000;19:3182-92.
31. Samuelson DJ, Aperavich BA, Haag JD, et al. Fine mapping reveals multiple loci and a possible epistatic interaction within the mammary carcinoma susceptibility quantitative trait locus, Mcs5. Cancer Res 2005;65:9637-42.
32. Zhang SL, DuBois W, Ramsay ES, et al. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol Cell Biol 2001; 21:310-8.
33. Warner SL, Munoz RM, Bearss DJ, et al. Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice. Pancreas 2008;37:39-44.
34. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002; 1602:73-87.
35. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
36. Culhaci N, Sagol O, Karademir S, et al. Expression of transforming growth factor-β-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer 2005;5:98.
37. Zhang Z, Wang Y, Herzog CR, et al. A strong candidate for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression. Oncogene 2002;21:5960-6.
38. Hideaki K, Shomei R, Tomohiko H, et al. Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration. J Gastroenterol 2005;40:511-7.
39. Karhu R, Mahlamäki E, Kallioniemi A. Pancreatic adenocarcinoma - genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 2006;45:721-30.